AAP
DNA icon

Arax Advisory Partners’s Ginkgo Bioworks DNA Stock Holding History

Arax Advisory Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$252 Buy
41
+38
+1,267% +$316 ﹤0.01% 3513
2025
Q4 		$25 Sell
3
-92
-97% -$991 ﹤0.01% 4006
2025
Q3 		$1.39K Buy
+95
New +$1.14K ﹤0.01% 3186
2024
Q4 		– Sell
-40
Closed -$326 – 2506
2024
Q3 		$326 Sell
40
-1
-2% -$10 ﹤0.01% 2460
2024
Q2 		$544 Buy
+41
New +$1.22K ﹤0.01% 2317

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arax Advisory Partners's DNA Position: Q1 2026 in Review

Arax Advisory Partners increased its Ginkgo Bioworks (DNA) stake by 1,267% in Q1 2026, buying an estimated $316 and bringing the position to 41 shares worth $252. The position accounts for ﹤0.01% of the portfolio, ranked #3513.

Arax Advisory Partners first reported a position in DNA in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.39K in Q3 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Arax Advisory Partners held 41 shares of Ginkgo Bioworks worth $252 as of Q1 2026.
  • Arax Advisory Partners bought 38 Ginkgo Bioworks shares in Q1 2026, an estimated $316.
  • Ginkgo Bioworks made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #3513 holding.
  • Arax Advisory Partners first reported a position in Ginkgo Bioworks in Q2 2024 and has held it in 5 quarters since.
  • Arax Advisory Partners's Ginkgo Bioworks position peaked at $1.39K in Q3 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.